$16.90
14.89% day before yesterday
Nasdaq, Dec 27, 10:09 pm CET
ISIN
US74340E1038
Symbol
PGNY

Progyny Inc Stock price

$16.90
+1.42 9.17% 1M
-11.72 40.95% 6M
-20.28 54.55% YTD
-20.86 55.24% 1Y
-35.22 67.57% 3Y
-11.05 39.53% 5Y
+0.96 6.02% 10Y
Nasdaq, Closing price Fri, Dec 27 2024
+2.19 14.89%
ISIN
US74340E1038
Symbol
PGNY
Sector
Industry

Key metrics

Market capitalization $1.44b
Enterprise Value $1.22b
P/E (TTM) P/E ratio 29.11
EV/FCF (TTM) EV/FCF 7.62
EV/Sales (TTM) EV/Sales 1.07
P/S ratio (TTM) P/S ratio 1.26
P/B ratio (TTM) P/B ratio 3.43
Revenue growth (TTM) Revenue growth 10.24%
Revenue (TTM) Revenue $1.14b
EBIT (operating result TTM) EBIT $65.47m
Free Cash Flow (TTM) Free Cash Flow $160.41m
Cash position $235.72m
EPS (TTM) EPS $0.58
P/E forward 31.41
P/S forward 1.26
EV/Sales forward 1.07
Short interest 16.98%
Show more

Is Progyny Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.

Progyny Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a Progyny Inc forecast:

3x Buy
30%
7x Hold
70%

Analyst Opinions

10 Analysts have issued a Progyny Inc forecast:

Buy
30%
Hold
70%

Financial data from Progyny Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
1,139 1,139
10% 10%
100%
- Direct Costs 892 892
11% 11%
78%
247 247
9% 9%
22%
- Selling and Administrative Expenses 178 178
3% 3%
16%
- Research and Development Expense - -
-
-
68 68
27% 27%
6%
- Depreciation and Amortization 2.94 2.94
41% 41%
0%
EBIT (Operating Income) EBIT 65 65
27% 27%
6%
Net Profit 57 57
10% 10%
5%

In millions USD.

Don't miss a Thing! We will send you all news about Progyny Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Progyny Inc Stock News

Negative
CNBC
5 days ago
It's been nearly five years since the coronavirus broke out in the U.S., but digital health companies are still reeling from the aftermath. According to a CNBC analysis of 39 public digital health companies, around two-thirds have lost value this year, while the Nasdaq is up 32%.
Neutral
PRNewsWire
10 days ago
SAN DIEGO , Dec. 18, 2024 /PRNewswire/ -- Shareholder rights law firm Robbins LLP is investigating Progyny, Inc. (NASDAQ: PGNY) to determine whether certain Progyny officers and directors violated securities laws and breached fiduciary duties to shareholders. Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United...
Neutral
GlobeNewsWire
11 days ago
SAN DIEGO, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Johnson Fistel, LLP is investigating whether Progyny, Inc. (NASDAQ: PGNY) or others violated securities laws by misrepresenting or failing to timely disclose material adverse to investors. The investigation focuses on investors' losses and whether they may be recovered under federal securities laws.
More Progyny Inc News

Company Profile

Progyny, Inc. is a medical device company. It engages in the field of reproductive medicine, translating scientific discoveries related to early embryo development into clinical tools. The firm operates through the following segments: medical device and fertility benefits solution. The company's services include egg freezing, IVF treatment, surrogacy, podcast, adoption, and Eeva Test. The company was founded on April 03, 2008 and is headquartered in New York, NY.

Head office United States
CEO Peter Anevski
Employees 566
Founded 2008
Website www.progyny.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today